Navigation Links
Drug therapy for allergy moves forward
Date:5/12/2014

Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy. Completed in a large-scale EU project, the lead author of the review article is Professor Ilkka Harvima of the University of Eastern Finland and Kuopio University Hospital.

Immediate allergic reactions and allergic diseases such as allergic rhinitis, asthma and urticaria are extremely widespread in the population. Traditionally, drug therapy for allergy is based on the use of non-sedative antihistamines, i.e. blocking of the histamine H1 receptors, but sometimes additional help is obtained from blockers of the cysteinyl leukotriene receptor-1.

Antihistamines seek to prevent allergic symptoms caused by histamine released by mast cells. Mast cells, also known as "allergy cells", are cells of the immune system which become activated by environmental allergens.

"However, even high doses of H1 antihistamine drugs aren't enough to alleviate the symptoms of some patients. This is understandable, as when the mast cell becomes activated, several other strong mediators besides histamine get released, too. Histamine can also affect other receptors of the cell surface than the H1 receptor," Professor Harvima explains.

Over the past years, researchers have identified several mast cell molecules which can be targets of new drugs. Several of these have already proceeded to clinical trials. These targets include, for example, serine proteinases tryptase, chymase, cathepsin G, which are enzymes that break down proteins, as well as 5-lipoxygenase-activating protein FLAP, 15-lipoxygenase-1, prostaglandin-D2, and proinflammatory cytokines such as TNF-alpha, IL-4, IL-6 and IL-17. New drugs targeting the histamine H4 receptor are
'/>"/>

Contact: Ilkka Harvima
ilkka.harvima@kuh.fi
358-447-172-875
University of Eastern Finland
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Two-lock box delivers cancer therapy
2. WHI reports $37.1B economic return on combined hormone therapy clinical trial
3. Study finds family-based exposure therapy effective treatment for young children with OCD
4. No credible evidence to support cardiac risk of testosterone therapy
5. Outcomes of steroid therapy following surgery for infants with bile duct disorder
6. New combination therapy developed for multiple myeloma
7. New model can predict therapy outcomes in prostate cancer with bone metastasis
8. Stress research in therapy dogs reveals animals needs
9. Receiving chemotherapy after a breast cancer diagnosis may affect a patients employment
10. ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer
11. Massage therapy improves circulation, eases muscle soreness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... York, New York (PRWEB) , ... July 31, 2015 , ... ... to strut their stuff, Super-Sod debuted their new type of sod called Leisure ... registered trademark application in process. , To commemorate introduction of this new type of ...
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on ... Super Bowl. In the two weeks that separate the conference championships and the Super Bowl, ... Bowl game will mark the 50th time it has been held and the festivities will ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s only ... was also the first provider of Exilis non-surgical fat reduction in New York. ... has attracted a large International clientele. Many patients travel to New York to ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... new store run by GoodThreads. The store can be accessed by visiting ... many of which are customizable. The best part: whenever a product is purchased, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade ... outer thighs. The original applicator required a 2 hour treatment time. The ...
Breaking Medicine News(10 mins):Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3
... Philadelphia, PA Louis J. Soslowsky, Ph.D. Fairhill ... director of the McKay Orthopaedic Research Laboratory and ... of Pennsylvania School of Medicine, was named the ... Delta Award by the American Academy of Orthopaedic ...
... ... at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein ... , ... (Vocus) March 10, 2010 -- An experimental thyroid drug reduces cholesterol without the troublesome ...
... ... Improves Team Collaboration and Efficiency , ... San Francisco, CA (PRWEB) March 10, 2010 -- Manymoon announced today ... in the Google Apps Marketplace™, Google,s recently launched online storefront for Google Apps™ products ...
... , ... , ... ... ANN ARBOR, Mich. , March 10 Many Americans will lose an hour of sleep on March 14 ...
... Discovery in mouse study may someday extend men,s lives, ... therapy has proven useful in treating late-stage prostate cancer, ... tumors that are resistant to such therapy. , Now, ... a mechanism by which the secondary tumors gain their ...
... ... Recognized for PrescriptionDrugs.com Business Plan , ... Boston, MA (PRWEB) March 11, 2010 -- A week from today, ... ever HBS Alumni New Venture Contest . PrescriptionDrugs.com co-founder Mike “Zappy” Zapolin will ...
Cached Medicine News:Health News:Penn researcher, Louis J. Soslowsky, PhD, winner of the AAOS Kappa Delta Ann Doner Vaughan Award 2Health News:Penn researcher, Louis J. Soslowsky, PhD, winner of the AAOS Kappa Delta Ann Doner Vaughan Award 3Health News:Thyroid Hormone Analogue for Treating High Cholesterol 2Health News:Thyroid Hormone Analogue for Treating High Cholesterol 3Health News:Manymoon Now Available Through the Google Apps Marketplace 2Health News:Manymoon Now Available Through the Google Apps Marketplace 3Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 2Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 3Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 4Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 3Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 2Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 3
(Date:7/30/2015)... -- Amgen (NASDAQ: AMGN ) today announced the appointment of ... Pincus LLC, to the Amgen Board of Directors. ... and the deep, global experience he brings in the biopharmaceuticals ... , chairman and chief executive officer of Amgen. "Fred,s breadth of ... Mr. Hassan has been Partner and Managing Director ...
(Date:7/30/2015)...  Cleveland Clinic President Wael Barsoum , M.D. ... that industry is compelled to adopt declining reimbursements throughout ... develop the transformational innovations -- required to thrive in ... by Doug Kohrs , past President and CEO ... that industry must add "episode of care," also known ...
(Date:7/30/2015)... July 30, 2015  Growth of the U.S. nonprescription ... bring former prescription users to the OTC market. Due ... forecasts robust Rx-to-OTC switch activity over the next five ... with many new brands entering the market into existing ... next five years (even those with low to moderate ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... YORK, July 19, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0574348/European-Medical-Displays-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging This research ... market in terms of the challenges faced ...
... drug companies face a number of obstacles to commercialize ... (FDA) and GMP compliance, to distribution agreements and the ... must be coordinated.  Those issues have just become easier ... VPCI have entered into a joint association.  The collaboration ...
Cached Medicine Technology:European Medical Displays Markets 2European Medical Displays Markets 3European Medical Displays Markets 4Spanish Drug Companies Have New Support Option for the U.S. Market 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: